CLC Number:
| [1] 钱桂生,余时沧.肺癌流行病学最新资料与启示[J].中华结核和呼吸杂志,2012,35(2): 86-89. [2] 许家琏.肺结核与肺癌的关系[J].中国临床医生,2004,32(7): 8-10. [3] 刘凤仁,叶临湘,梁享生,等.影响肺结核治疗转归的因素分析[J].中国防痨杂志,2006,28(4): 247-249. [4] 朱琦,孙学智,曾洁.76 例肺癌合并肺结核临床特点分析[J].临床肺科杂志,2011,16(8): 1233-1234. [5] 肖怀清,杜开齐,张志豪,等.肺结核并肺癌 37 例临床分析[J].临床误诊误治,2011,24(3): 43-44. [6] 曾祥丽,李新华,马红昌.肺结核合并肺癌 33 例临床及影像学特点分析[J].中国临床研究,2011,24(8): 680-681. [7] 阮军忠,王子彤,李世业.肺结核合并肺癌 89 例临床分析[J].中国防痨杂志,2008,30(5): 448-451. |
| [1] | XU Nianxing, WEI Dong, QIAO Junjie, ZHAN Bingyan. Predictive value of CD8+, IL-6, and PaO2 for immunotherapy-triggered radiation recall pneumonitis in unresectable stage ⅢB/C and IV non-small cell lung cancer [J]. Journal of Shandong University (Health Sciences), 2025, 63(2): 29-35. |
| [2] | Mingyong HAN,Xiaoli YU,Fangping ZENG,Bing XIE,Lan LU,Jiaquan QU,Bifeng JIANG,Sihan TANG,Jie TAN,Jin LIANG,Longhui ZHONG,Liu WANG,Xuanzhi ZHAO. Technical procedure of CT-guided intratumoral chemotherapy for lung tumor [J]. Journal of Shandong University (Health Sciences), 2023, 61(11): 11-19. |
| [3] | . [J]. Journal of Shandong University (Health Sciences), 2022, 60(11): 127-129. |
| [4] | Yue PENG,Lei LIU,Yuan LI,Fenglong BIE,Bolun ZHOU,Runze LI,Ying JI,Guangyu BAI,Fengwei TAN,Yushun GAO,Juwei MU,Qi XUE,Bin QIU,Shugeng GAO. Comprehensive application of anatomical partial lobectomy and enhanced recovery after surgery [J]. Journal of Shandong University (Health Sciences), 2022, 60(11): 44-53. |
| [5] | Huining LIU,Jun PENG,Yingchun REN,Guang YANG,Wenhao WANG,Jinfeng LIU,Qing TIAN. Comparison of 34 cases of thoracoscopic wedge resection and 21 cases of segmental resection for stage ⅠA1 non-small cell lung cancer in area P [J]. Journal of Shandong University (Health Sciences), 2022, 60(11): 38-43. |
| [6] | Huijiang GAO,Yucheng WEI. Minimally invasive sleeve lobectomy: opportunities and challenges in the era of immunotherapy [J]. Journal of Shandong University (Health Sciences), 2022, 60(11): 23-27. |
| [7] | Shugeng GAO. Application of enhanced recovery after surgery in perioperative management of lung cancer [J]. Journal of Shandong University (Health Sciences), 2022, 60(11): 1-10. |
| [8] | YANG Xiuting, LIU Qigong, ZUO Ping, LIU Zhengxiang, ZUO Houjuan. Effect of CD151-MUT mutation on migration of lung adenocarcinoma cell line A549 and its mechanism [J]. Journal of Shandong University (Health Sciences), 2020, 58(3): 81-86. |
| [9] | . Expert consensus on laboratory diagnosis of lung cancer [J]. Journal of Shandong University (Health Sciences), 2018, 56(10): 9-17. |
| [10] | PAN Shiyang. Research advances in markers for the evaluation of lung cancer efficacy [J]. Journal of Shandong University (Health Sciences), 2018, 56(10): 31-39. |
| [11] | PENG Yue, FENG Zhen, XIE Hounai, WANG Hui, LI Meng, REN Wangang, LIU Tong, PENG Zhongmin. Surgical treatment for 61 patients with multiple lung lesions [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(11): 42-46. |
| [12] | WANG Lili, HUO Bin, WANG Lei, WANG Hao, HOU Dingkun, HUO Xiaodong, WANG Jinhuan, ZANG Li, CAO Qiang, CHAI Shude, WANG Haitao. Meta-analysis and system evaluation of 125I implantation in the treatment of early lung cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(10): 76-83. |
| [13] | LI Xingkai, LIU Zhanye, JIANG Yunfeng, LI Jun. Clinicopathological factors and prognosis between primary central and peripheral lung squamous cell carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(9): 73-78. |
| [14] | HUANG Zhuqing, WU Xuewei, REN Dongmei. Isolation and identification of phenolic constituents from Viscum coloratum and the antiproliferative effects on A549 cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(8): 35-41. |
| [15] | ZENG Haiyan, LI Rui, SUN Xindong, XIE Peng, MENG Xue, FAN Bingjie, LI Wanlong, YUAN Shuanghu. Association analysis of brain metastases after prophylactic cranial irradiation in local disease small cell lung cancer: a bicenter study [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(7): 61-66. |
|
||
